Elsevier

Pathology

Volume 30, Issue 4, 1998, Pages 386-390
Pathology

South australian scleroderma register: Analysis of deceased patients

https://doi.org/10.1080/00313029800169676Get rights and content

Summary

The demographic, clinical, pathological and serological features of 123 deceased patients with systemic sclerosis have been analysed. These patients consisted of all identified patients dying with this disease in South Australia between 1983 and 1996 inclusive. There were 85 females and 38 males, with the ratio of limited:diffuse:overlap disease subset being 9:5:1. Disease characteristics revealed that patients with the limited disease tended to be female with high frequencies of the centromere autoantibody, while patients with the diffuse disease had equal gender representation with the frequent presence of nucleolar, speckled or homogeneous antinuclear antibody. Mean duration of disease and mean age of death for the limited:diffuse:overlap subsets differed significantly between groups (p<0.05) and were 16.5, 9.3 and 10.9 years and 71.9, 57.8 and 52.8 years respectively. Cumulative survival curves for the subsets differed highly significantly, with patients with the limited diseases dying more commonly from right heart failure (documented terminally in 25% of the centromere positive limited subset), cardiovascular disease or cancer, while patients with the diffuse subset died from respiratory failure, renal failure or cardiovascular disease.

In conclusion, this retrospective analysis has revealed that scleroderma is a relatively common but clinically heterogeneous disorder. There are important clinical and prognostic implications in defining limited versus diffuse versus overlap disease.

References (12)

  • E.C. LeRoy et al.

    Editorial. Scleroderma: classification, subset and pathogenesis

    J Rheumatol

    (1988)
  • J.D. Reveille et al.

    Association of amino acid sequences in the HLA-DQB1 first domain with the anti-topoisomerase I autoantibody response in scleroderma (progressive system sclerosis)

    J Clin Invest

    (1992)
  • M. Kuwana et al.

    The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma)

    J Clin Invest

    (1993)
  • G. Chandran et al.

    A study of scleroderma in South Australia: prevalence, subset characteristics and nailfold capillaroscopy

    Aust NZ J Med

    (1995)
  • G. Chandran et al.

    The abnormalities of nailfold capillaries in scleroderma as assessed by video image analysis and photomicroscopy

    Asian Pacific J lmmunol Allergy

    (1996)
  • H.J. Englert

    The epidemiology of scleroderma in Sydney, 1974-1988; a comparative study

    Thesis for Doctor of Philosophy, Department of Medicine, University of Sydney,

    (1993)
There are more references available in the full text version of this article.

Cited by (18)

  • Mortality and survival in systemic sclerosis: Systematic review and meta-analysis

    2014, Seminars in Arthritis and Rheumatism
    Citation Excerpt :

    This last data is obviously a more imprecise data but certainly more real. Several survival and mortality studies from single cohorts [1,3,8–79] and reviews have been published from the last mid-century, reporting data about cumulative survival at different times of follow-up and measured sometimes from the onset of disease and sometimes from the time of diagnosis. This is crucial at the time of meta-analyzing these data and to avoid any bias of selection.

  • Scleroderma epidemiology

    2003, Rheumatic Disease Clinics of North America
  • Pulmonary Hypertension Complicating Connective Tissue Disease

    2017, Seminars in Respiratory and Critical Care Medicine
View all citing articles on Scopus
View full text